{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:45:45Z","timestamp":1791420345688,"version":"4.3.3"},"reference-count":109,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2016,3,4]],"date-time":"2016-03-04T00:00:00Z","timestamp":1457049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cancer, being the second leading cause of mortality, exists as a formidable health challenge. In spite of our enormous efforts, the emerging complexities in the molecular nature of disease progression limit the real success in finding an effective cancer cure. It is now conceivable that cancer is, in fact, a progressive illness, and the morbidity and mortality from cancer can be reduced by interfering with various oncogenic signaling pathways. A wide variety of structurally diverse classes of bioactive phytochemicals have been shown to exert anticancer effects in a large number of preclinical studies. Multiple lines of evidence suggest that withaferin-A can prevent the development of cancers of various histotypes. Accumulating data from different rodent models and cell culture experiments have revealed that withaferin-A suppresses experimentally induced carcinogenesis, largely by virtue of its potent anti-oxidative, anti-inflammatory, anti-proliferative and apoptosis-inducing properties. Moreover, withaferin-A sensitizes resistant cancer cells to existing chemotherapeutic agents. The purpose of this review is to highlight the mechanistic aspects underlying anticancer effects of withaferin-A.<\/jats:p>","DOI":"10.3390\/ijms17030290","type":"journal-article","created":{"date-parts":[[2016,3,4]],"date-time":"2016-03-04T10:53:34Z","timestamp":1457088814000},"page":"290","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":148,"title":["Withaferin-A\u2014A Natural Anticancer Agent with Pleitropic Mechanisms of Action"],"prefix":"10.3390","volume":"17","author":[{"given":"In-Chul","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Cosmetic science, Seowon University, Cheongju, Chungbuk 361-742, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bu","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Science &amp; Engineering, Seowon University, Cheongju, Chungbuk 361-742, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,3,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncponc0140","article-title":"Mechanisms of disease: Inflammatory mediators and cancer prevention","volume":"2","author":"Mann","year":"2005","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15430\/JCP.2014.19.1.1","article-title":"Non-edible plants as an attractive source of compounds with chemopreventive potential","volume":"19","author":"Ji","year":"2014","journal-title":"J. Cancer Prev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nrc1189","article-title":"Cancer chemoprevention with dietary phytochemicals","volume":"3","author":"Surh","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12248-013-9531-1","article-title":"Molecular targets and mechanisms of cancer prevention and treatment by withaferin-A, a naturally occurring steroidal lactone","volume":"16","author":"Vyas","year":"2014","journal-title":"AAPS J."},{"key":"ref_5","first-page":"511","article-title":"The antibacterial principle of Withania somnifera. I. Isoation and antibacterial activity","volume":"8","author":"Kurup","year":"1958","journal-title":"Antibiot. Chemother."},{"key":"ref_6","first-page":"169","article-title":"In vivo growth inhibitory effect of Withania somnifera (Ashwagandha) on a transplantable mouse tumor, Sarcoma 180","volume":"30","author":"Devi","year":"1992","journal-title":"Indian J. Exp. Biol."},{"key":"ref_7","first-page":"165","article-title":"Effect of Withania somnifera on 20-methylcholanthrene induced fibrosarcoma","volume":"19","author":"Davis","year":"2000","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/ptr.779","article-title":"Chemopreventive activity of Withania somnifera in experimentally induced fibrosarcoma tumours in Swiss albino mice","volume":"15","author":"Prakash","year":"2001","journal-title":"Phytother. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-8741(00)00404-9","article-title":"Effect of Withania somnifera on DMBA induced carcinogenesis","volume":"75","author":"Davis","year":"2001","journal-title":"J. Ethnopharmacol."},{"key":"ref_10","first-page":"1519","article-title":"Effect of an extract of Withania somnifera root on estrogen receptor-positive mammary carcinomas","volume":"33","author":"Khazal","year":"2013","journal-title":"Anticancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/jbt.20235","article-title":"Protective role of withaferin-A on 7,12-dimethylbenz(a)anthracene-induced genotoxicity in bone marrow of Syrian golden hamsters","volume":"22","author":"Panjamurthy","year":"2008","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_12","first-page":"271","article-title":"Antitumor activity of withaferin-A (NSC-101088)","volume":"51","author":"Shohat","year":"1967","journal-title":"Cancer Chemother. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-3835(76)80014-6","article-title":"The effect of withaferin-A, a natural steroidal lactone, on the fine structure of S-180 tumor cells","volume":"2","author":"Shohat","year":"1976","journal-title":"Cancer Lett."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0304-3835(95)03892-Z","article-title":"In vivo growth inhibitory and radiosensitizing effects of withaferin-A on mouse Ehrlich ascites carcinoma","volume":"95","author":"Devi","year":"1995","journal-title":"Cancer Lett."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1269\/jrr.44.1","article-title":"Radiosensitizing effect of withaferin-A combined with hyperthermia on mouse fibrosarcoma and melanoma","volume":"44","author":"Kamath","year":"2003","journal-title":"J. Radiat. Res."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Lahat, G., Zhu, Q.S., Huang, K.L., Wang, S., Bolshakov, S., Liu, J., Torres, K., Langley, R.R., Lazar, A.J., and Hung, M.C. (2010). Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010105"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1158\/1078-0432.CCR-06-0948","article-title":"Selective killing of cancer cells by leaf extract of Ashwagandha: Identification of a tumor-inhibitory factor and the first molecular insights to its effect","volume":"13","author":"Widodo","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1124\/mol.106.030015","article-title":"The tumor proteasome is a primary target for the natural anticancer compound Withaferin-A isolated from \u201cIndian winter cherry\u201d","volume":"71","author":"Yang","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.1158\/0008-5472.CAN-08-1510","article-title":"Withaferin-A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo","volume":"68","author":"Stan","year":"2008","journal-title":"Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1002\/ijc.25938","article-title":"Withaferin-A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation","volume":"129","author":"Thaiparambil","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/jnci\/djt153","article-title":"Metabolic alterations in mammary cancer prevention by withaferin-A in a clinically relevant mouse model","volume":"105","author":"Hahm","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/carcin\/bgr192","article-title":"Withaferin-A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells","volume":"32","author":"Munagala","year":"2011","journal-title":"Carcinogenesis"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kakar, S.S., Ratajczak, M.Z., Powell, K.S., Moghadamfalahi, M., Miller, D.M., Batra, S.K., and Singh, S.K. (2014). Withaferin-A alone and in combination with cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0107596"},{"key":"ref_24","first-page":"432","article-title":"Radiosensitization of a mouse melanoma by withaferin A: In vivo studies","volume":"38","author":"Devi","year":"2000","journal-title":"Indian J. Exp. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s13277-012-0363-x","article-title":"Natural withanolide withaferin-A induces apoptosis in uveal melanoma cells by suppression of Akt and c-MET activation","volume":"33","author":"Samadi","year":"2012","journal-title":"Tumour Biol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Li, W., Zhang, C., Du, H., Huang, V., Sun, B., Harris, J.P., Richardson, Q., Shen, X., Jin, R., and Li, G. (2015). Withaferin-A suppresses the up-regulation of acetyl-coA carboxylase 1 and skin tumor formation in a skin carcinogenesis mouse model. Mol. Carcinog.","DOI":"10.1002\/mc.22423"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.surg.2010.09.026","article-title":"A novel RET inhibitor with potent efficacy against medullary thyroid cancer in vivo","volume":"148","author":"Samadi","year":"2010","journal-title":"Surgery"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Yang, H., Wang, Y., Cheryan, V.T., Wu, W., Cui, C.Q., Polin, L.A., Pass, H.I., Dou, Q.P., Rishi, A.K., and Wali, A. (2012). Withaferin-A inhibits the proteasome activity in mesothelioma in vitro and in vivo. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0041214"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1734-1140(09)70125-2","article-title":"Circadian time-dependent chemopreventive potential of withaferin-A in 7,12-dimethylbenz[a]anthracene-induced oral carcinogenesis","volume":"61","author":"Manoharan","year":"2009","journal-title":"Pharmacol. Rep."},{"key":"ref_30","first-page":"16","article-title":"Protective effect of Withaferin-A on tumour formation in 7,12-dimethylbenz[a]anthracene induced oral carcinogenesis in hamsters","volume":"47","author":"Manoharan","year":"2009","journal-title":"Indian J. Exp. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10637-008-9199-z","article-title":"Protective role of Withaferin-A on immunoexpression of p53 and bcl-2 in 7,12-dimethylbenz(a)anthracene -in duced experimental oral carcinogenesis","volume":"27","author":"Panjamurthy","year":"2009","journal-title":"Investig. New Drugs"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.bcp.2009.09.017","article-title":"Withaferin-A targets heat shock protein 90 in pancreatic cancer cells","volume":"79","author":"Yu","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.15430\/JCP.2015.20.3.185","article-title":"Withaferin-A inhibits colon cancer cell growth by blocking STAT3 transcriptional activity","volume":"20","author":"Choi","year":"2015","journal-title":"J. Cancer Prev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11060-015-1972-1","article-title":"AshwaMAX and Withaferin-A inhibits gliomas in cellular and murine orthotopic models","volume":"126","author":"Chang","year":"2015","journal-title":"J. Neurooncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.freeradbiomed.2012.02.035","article-title":"Emerging avenues linking inflammation and cancer","volume":"52","author":"Kundu","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.taap.2012.04.025","article-title":"Barrier protective effects of withaferin-A in HMGB1-induced inflammatory responses in both cellular and animal models","volume":"262","author":"Lee","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.intimp.2011.02.029","article-title":"Withaferin-A down-regulates lipopolysaccharide-induced cyclooxygenase-2 expression and PGE2 production through the inhibition of STAT1\/3 activation in microglial cells","volume":"11","author":"Min","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00125-012-2813-9","article-title":"Withaferin-A inhibits pro-inflammatory cytokine-induced damage to islets in culture and following transplantation","volume":"56","author":"SoRelle","year":"2013","journal-title":"Diabetologia"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1055\/s-0028-1088302","article-title":"Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals","volume":"74","author":"Surh","year":"2008","journal-title":"Planta Med."},{"key":"ref_41","first-page":"236","article-title":"Antioxidant activity of glycowithanolides from Withania somnifera","volume":"35","author":"Bhattacharya","year":"1997","journal-title":"Indian J. Exp. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bcp.2015.07.024","article-title":"Withaferin-A reduces acetaminophen-induced liver injury in mice","volume":"97","author":"Jadeja","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.freeradbiomed.2013.10.819","article-title":"Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1","volume":"67","author":"Na","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"ref_44","first-page":"1","article-title":"Protective effect of Withaferin-A on micronucleus frequency and detoxication agents during experimental oral carcinogenesis","volume":"6","author":"Panjamurthy","year":"2008","journal-title":"Afr. J. Tradit. Complement. Altern. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1186\/1471-2164-11-S4-S25","article-title":"Inhibition of the NEMO\/IKK\u03b2 association complex formation, a novel mechanism associated with the NF-\u03baB activation suppression by Withania somnifera's key metabolite withaferin A","volume":"11","author":"Grover","year":"2010","journal-title":"BMC Genom."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bcp.2014.08.004","article-title":"Withaferin-A inhibits NF-\u03baB activation by targeting cysteine 179 in IKK\u03b2","volume":"91","author":"Heyninck","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/ijc.23173","article-title":"Inflammation and cancer: An ancient link with novel potentials","volume":"121","author":"Hussain","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.mrfmmm.2005.04.019","article-title":"Breaking the relay in deregulated cellular signal transduction as a rationale for chemoprevention with anti-inflammatory phytochemicals","volume":"591","author":"Kundu","year":"2005","journal-title":"Mutat. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mrrev.2008.03.002","article-title":"Inflammation: Gearing the journey to cancer","volume":"659","author":"Kundu","year":"2008","journal-title":"Mutat. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejphar.2008.09.017","article-title":"Withaferin-A inhibits iNOS expression and nitric oxide production by Akt inactivation and down-regulating LPS-induced activity of NF-\u03baB in RAW 264.7 cells","volume":"599","author":"Oh","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.tiv.2011.01.010","article-title":"Endoplasmic reticulum stress mediates withaferin-A-induced apoptosis in human renal carcinoma cells","volume":"25","author":"Choi","year":"2011","journal-title":"Toxicol. In Vitro"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"381964","DOI":"10.1155\/2015\/381964","article-title":"Withaferin-A inhibits nuclear factor-\u03baB-dependent pro-inflammatory and stress response pathways in the astrocytes","volume":"2015","author":"Martorana","year":"2015","journal-title":"Neural Plast."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3892\/mmr.2015.4602","article-title":"Inhibitory effect of withaferin-A on Helicobacter pyloriinduced IL8 production and NF\u03baB activation in gastric epithelial cells","volume":"13","author":"Kim","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.fct.2014.03.009","article-title":"Withaferin-A is an inhibitor of endothelial protein C receptor shedding in vitro and in vivo","volume":"68","author":"Ku","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bcp.2014.06.022","article-title":"Withaferin-A modulates the Spindle assembly checkpoint by degradation of Mad2-Cdc20 complex in colorectal cancer cell lines","volume":"91","author":"Das","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s10637-014-0084-7","article-title":"Oxidative cytotoxic agent withaferin-A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt\/mTOR pathway inhibitory modulation","volume":"32","author":"Grogan","year":"2014","journal-title":"Investig. New Drugs"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3892\/etm.2015.2480","article-title":"Antiproliferation potential of withaferin A on human osteosarcoma cells via the inhibition of G2\/M checkpoint proteins","volume":"10","author":"Lv","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1021\/np400441f","article-title":"Withaferin-A, a steroidal lactone from Withania somnifera, induces mitotic catastrophe and growth arrest in prostate cancer cells","volume":"76","author":"Roy","year":"2013","journal-title":"J. Nat. Prod."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"707586","DOI":"10.5402\/2012\/707586","article-title":"Withaferin-A induces proteasome-dependent degradation of breast cancer susceptibility gene 1 and heat shock factor 1 proteins in breast cancer cells","volume":"2012","author":"Zhang","year":"2012","journal-title":"ISRN Biochem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ygyno.2011.11.044","article-title":"Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin-A","volume":"124","author":"Zhang","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1158\/1535-7163.MCT-09-0771","article-title":"Notch-1 inhibition by Withaferin-A: A therapeutic target against colon carcinogenesis","volume":"9","author":"Koduru","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.7314\/APJCP.2014.15.4.1711","article-title":"Effect of Withaferin-A on A549 cellular proliferation and apoptosis in non-small cell lung cancer","volume":"15","author":"Cai","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1080\/15384047.2015.1046651","article-title":"Anti-cancer activity of withaferin-A in B-cell lymphoma","volume":"16","author":"McKenna","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1074\/jbc.M113.496844","article-title":"Growth arrest by the antitumor steroidal lactone withaferin-A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of \u03b2-tubulin","volume":"289","author":"Antony","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Nishikawa, Y., Okuzaki, D., Fukushima, K., Mukai, S., Ohno, S., Ozaki, Y., Yabuta, N., and Nojima, H. (2015). Withaferin A induces cell death selectively in androgen-independent prostate cancer cells but not in normal fibroblast cells. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0134137"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1158\/0008-5472.CAN-06-2430","article-title":"Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells","volume":"67","author":"Srinivasan","year":"2007","journal-title":"Cancer Res."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Lee, H.E., Shin, J.A., Jeong, J.H., Jeon, J.G., Lee, M.H., and Cho, S.D. (2015). Anticancer activity of Ashwagandha against human head and neck cancer cell lines. J. Oral Pathol. Med.","DOI":"10.1111\/jop.12353"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.freeradbiomed.2009.03.022","article-title":"Withaferin-A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP","volume":"46","author":"Lee","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1007\/s10495-007-0129-x","article-title":"Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin-A with concomitant protection by N-acetyl cysteine","volume":"12","author":"Malik","year":"2007","journal-title":"Apoptosis"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s10495-011-0625-x","article-title":"Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2","volume":"16","author":"Mayola","year":"2011","journal-title":"Apoptosis"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejphar.2013.11.031","article-title":"Molecular mechanisms of hyperthermia-induced apoptosis enhanced by withaferin A","volume":"723","author":"Cui","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.canlet.2012.08.026","article-title":"Withaferin-A-induced apoptosis in human breast cancer cells is associated with suppression of inhibitor of apoptosis family protein expression","volume":"334","author":"Hahm","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/mc.20760","article-title":"Withaferin-A suppresses estrogen receptor-\u03b1 expression in human breast cancer cells","volume":"50","author":"Hahm","year":"2011","journal-title":"Mol. Carcinog."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1472-6882-11-84","article-title":"Down-regulation of estrogen receptor-\u03b1 and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells","volume":"11","author":"Zhang","year":"2011","journal-title":"BMC Complement. Altern. Med."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Hahm, E.R., Moura, M.B., Kelley, E.E., Van Houten, B., Shiva, S., and Singh, S.V. (2011). Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023354"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/embor.2010.203","article-title":"BAG3 mediates chaperone-based aggresome-targeting and selective autophagy of misfolded proteins","volume":"12","author":"Gamerdinger","year":"2011","journal-title":"EMBO Rep."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1007\/s10495-008-0271-0","article-title":"Withaferin A induces apoptosis by activating p38 mitogen-activated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin through mitochondrial death cascade","volume":"13","author":"Mandal","year":"2008","journal-title":"Apoptosis"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1158\/0008-5472.CAN-13-2081","article-title":"Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer","volume":"74","author":"Nagalingam","year":"2014","journal-title":"Cancer Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0960-9822(00)00728-4","article-title":"Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1","volume":"10","author":"Dijkers","year":"2000","journal-title":"Curr. Biol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Vaishnavi, K., Saxena, N., Shah, N., Singh, R., Manjunath, K., Uthayakumar, M., Kanaujia, S.P., Kaul, S.C., Sekar, K., and Wadhwa, R. (2012). Differential activities of the two closely related withanolides, Withaferin-A and Withanone: Bioinformatics and experimental evidences. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0044419"},{"key":"ref_81","first-page":"7255","article-title":"Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression","volume":"61","author":"Chakraborty","year":"2001","journal-title":"Cancer Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1128\/MCB.17.7.3823","article-title":"Expression and function of the leucine zipper protein Par-4 in apoptosis","volume":"17","author":"Sells","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2353\/ajpath.2010.091171","article-title":"Prostate apoptosis response-4 is expressed in normal cholangiocytes, is down-regulated in human cholangiocarcinoma, and promotes apoptosis of neoplastic cholangiocytes when induced pharmacologically","volume":"177","author":"Franchitto","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"15036","DOI":"10.1038\/cddiscovery.2015.36","article-title":"Current questions and possible controversies in autophagy","volume":"1","author":"Lindqvist","year":"2015","journal-title":"Cell Death Discov."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"102735","DOI":"10.1155\/2013\/102735","article-title":"Role of the crosstalk between autophagy and apoptosis in cancer","volume":"2013","author":"Su","year":"2013","journal-title":"J. Oncol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2174\/15680096113139990039","article-title":"Autophagy fails to alter withaferin-A-mediated lethality in human breast cancer cells","volume":"13","author":"Hahm","year":"2013","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Fong, M.Y., Jin, S., Rane, M., Singh, R.K., Gupta, R., and Kakar, S.S. (2012). Withaferin-A synergizes the therapeutic effect of doxorubicin through ROS-mediated autophagy in ovarian cancer. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0042265"},{"key":"ref_88","first-page":"138","article-title":"Withaferin A suppresses the expression of vascular endothelial growth factor in Ehrlich ascites tumor cells via Sp1 transcription factor","volume":"3","author":"Prasanna","year":"2009","journal-title":"Curr. Trends Biotechnol. Pharm."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Kumar, S.P., Thippeswamy, G., and Salimath, B.P. (2008). WITHDRAWN: Anti-tumor and proapoptotic effect of withaferin-A is mediated by up-regulation of Bax and inhibition NF-\u03baB in Ehrlich ascites tumor cells. Biochim. Biophys. Acta.","DOI":"10.1016\/j.bbagen.2008.11.003"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2193-9616-1-11","article-title":"Inhibition of VEGF: A novel mechanism to control angiogenesis by Withania somnifera's key metabolite Withaferin A","volume":"1","author":"Saha","year":"2013","journal-title":"In Silico Pharmacol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1158\/1535-7163.MCT-14-0324","article-title":"Withanone-rich combination of Ashwagandha withanolides restricts metastasis and angiogenesis through hnRNP-K","volume":"13","author":"Gao","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/mc.22110","article-title":"Withaferin-A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors","volume":"54","author":"Lee","year":"2015","journal-title":"Mol. Carcinog."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3892\/or.2013.2487","article-title":"Withaferin-A inhibits matrix metalloproteinase-9 activity by suppressing the Akt signaling pathway","volume":"30","author":"Lee","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Szarc vel Szic, K., Op de Beeck, K., Ratman, D., Wouters, A., Beck, I.M., Declerck, K., Heyninck, K., Fransen, E., Bracke, M., and De Bosscher, K. (2014). Pharmacological levels of Withaferin-A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0087850"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10549-012-2239-6","article-title":"Withaferin-A causes activation of Notch2 and Notch4 in human breast cancer cells","volume":"136","author":"Lee","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1476-4598-9-99","article-title":"Differential chemosensitization of P-glycoprotein overexpressing K562\/Adr cells by withaferin-A and Siamois polyphenols","volume":"9","author":"Suttana","year":"2010","journal-title":"Mol. Cancer"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.bbrc.2012.06.047","article-title":"Synergistic cytotoxic action of cisplatin and withaferin-A on ovarian cancer cell lines","volume":"423","author":"Kakar","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1158\/1541-7786.MCR-12-0511","article-title":"Stem cell marker nestin is critical for TGF-\u03b21-mediated tumor progression in pancreatic cancer","volume":"11","author":"Su","year":"2013","journal-title":"Mol. Cancer Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1158\/1940-6207.CAPR-13-0445","article-title":"Mammary cancer chemoprevention by withaferin-A is accompanied by in vivo suppression of self-renewal of cancer stem cells","volume":"7","author":"Kim","year":"2014","journal-title":"Cancer Prev. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"8948","DOI":"10.1158\/0008-5472.CAN-10-1936","article-title":"Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells","volume":"70","author":"Jo","year":"2010","journal-title":"Cancer Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1158\/0008-5472.CAN-06-0054","article-title":"Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells","volume":"66","author":"Liu","year":"2006","journal-title":"Cancer Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s00262-013-1470-2","article-title":"Myeloid-derived suppressor cell function is reduced by Withaferin-A, a potent and abundant component of Withania somnifera root extract","volume":"62","author":"Sinha","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.taap.2015.09.014","article-title":"Thiol dependent NF-\u03baB suppression and inhibition of T-cell mediated adaptive immune responses by a naturally occurring steroidal lactone Withaferin A","volume":"289","author":"Gambhir","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1074\/jbc.M606728200","article-title":"Withaferin-A strongly elicits I\u03baB kinase \u03b2 hyperphosphorylation concomitant with potent inhibition of its kinase activity","volume":"282","author":"Kaileh","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.yexcr.2014.09.034","article-title":"Withaferin-A disrupts ubiquitin-based NEMO reorganization induced by canonical NF-\u03baB signaling","volume":"331","author":"Jackson","year":"2015","journal-title":"Exp. Cell Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.3892\/or.2015.3837","article-title":"Association of annexin A2 with cancer development","volume":"33","author":"Xu","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nchembio755","article-title":"Actin microfilament aggregation induced by withaferin-A is mediated by annexin II","volume":"2","author":"Falsey","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1515\/hsz-2012-0184","article-title":"Withaferin-A binds covalently to the N-terminal domain of annexin A2","volume":"393","author":"Ozorowski","year":"2012","journal-title":"Biol. Chem."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Grin, B., Mahammad, S., Wedig, T., Cleland, M.M., Tsai, L., Herrmann, H., and Goldman, R.D. (2012). Withaferin-A alters intermediate filament organization, cell shape and behavior. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0039065"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/3\/290\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:20:08Z","timestamp":1760210408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/3\/290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,4]]},"references-count":109,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3]]}},"alternative-id":["ijms17030290"],"URL":"https:\/\/doi.org\/10.3390\/ijms17030290","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,4]]}}}